Sandisk Corporation (NASDAQ:SNDKV1), a leader in computer storage devices, has announced material modifications to the rights of its security holders and amendments to its Articles of Incorporation or ...
The company expects trading under the new ticker symbol of “EXOZ” to begin on February 12, 2025, subject to final approvals. In connection with the corporate name change, Company branding ...
NYSE Arca files for Grayscale Cardano ETF, offering ADA exposure under ticker GADA, enabling traditional stock market trading ...
Miami, FL., February 11, 2025 - The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as "Sono Group” or the "Company”, parent company to Sono Motors GmbH or "Sono Motors” ...
“We are pleased to welcome HomeTrust Bancshares, Inc. to the New York Stock Exchange,” said Tara Dziedzic, Head of US Listings, New York Stock Exchange. “As an NYSE-listed company, HomeTrust joins our ...
Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially ...
Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells. Exozymes can replace ...
Cashew nuts, represented by the ticker symbol SCSN, have surged over 17% year-to-date in the commodities market, outpacing cocoa to ...
and is now in the final phase of the process for its name and ticker symbol change. This milestone marks a significant step forward in the company's corporate growth strategy, aligning its ...
Thomson Reuters on Thursday said that it will transfer its U.S. listing onto the Nasdaq Global Select Market after being on the New York Stock Exchange for 16 years.
Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results